Emily Shaw
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 3
- Oncology 8
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Feiya Ma (1 shared paper)Xia Liu (1 shared paper)David M. Bagley (1 shared paper)Yuanqin Zhang (1 shared paper)Guangyong Peng (1 shared paper)Fusheng Si (1 shared paper)Judith Bernstein (1 shared paper)Edward Bernstein (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Drug Discovery Today (2 papers)Journal of Clinical Pathology (2 papers)Nature Communications (1 paper)BMC Pulmonary Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Emily Shaw
26 papers receiving 407 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 69
- Oncology 117
- Genetics 33
- Immunology 61
- Pathology and Forensic Medicine 42
Countries citing papers authored by Emily Shaw
This map shows the geographic impact of Emily Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Shaw more than expected).
Fields of papers citing papers by Emily Shaw
This network shows the impact of papers produced by Emily Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Shaw. The network helps show where Emily Shaw may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 71 | |
| 2 | 2023 | 67 | |
| 3 | 2009 | 55 | |
| 4 | 2014 | 49 | |
| 5 | 2004 | 29 | |
| 6 | 2012 | 26 | |
| 7 | 2019 | 22 | |
| 8 | 2014 | 22 | |
| 9 | 2021 | 19 | |
| 10 | 2016 | 15 | |
| 11 | 2024 | 5 | |
| 12 | 2015 | 4 | |
| 13 | 2017 | 4 | |
| 14 | Self management for chronic disease. An introduction. | 2001 | 4 |
| 15 | 2012 | 3 | |
| 16 | 2011 | 3 | |
| 17 | 2022 | 3 | |
| 18 | What's new in smoking cessation: Zyban. | 1999 | 3 |
| 19 | 2012 | 2 | |
| 20 | 2020 | 2 |
About Emily Shaw
Emily Shaw is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and General Health Professions, having authored 28 papers that have together received 415 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Breast Cancer Treatment Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Primary Care and Health Outcomes (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Food Security and Health in Diverse Populations (2 papers) and Cancer and Skin Lesions (2 papers). The work is most often cited by research in Cancer Research (69 citations), Oncology (117 citations), Genetics (33 citations), Immunology (61 citations) and Pathology and Forensic Medicine (42 citations). Emily Shaw has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Feiya Ma, Xia Liu, David M. Bagley, Yuanqin Zhang, Guangyong Peng, Fusheng Si, Judith Bernstein, Edward Bernstein, Deric Topp and Gareth J. Thomas. Their work appears in journals such as Journal of Clinical Oncology, Drug Discovery Today, Journal of Clinical Pathology, Nature Communications and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.